🇺🇸 FDA
Pipeline program

Kaftrio 37.5 mg/25 mg/50 mg film-coated tablets, Kalydeco 75 mg film-coated tablets, Kalydeco 150 mg film-coated tablets, Kaftrio 75 mg/50 mg/100 mg film-coated tablets

PKCAFTORs

Approved small_molecule active

Quick answer

Kaftrio 37.5 mg/25 mg/50 mg film-coated tablets, Kalydeco 75 mg film-coated tablets, Kalydeco 150 mg film-coated tablets, Kaftrio 75 mg/50 mg/100 mg film-coated tablets for Cystic Fibrosis is a Approved program (small_molecule) at Istituto Gentili S.r.l. with 1 ClinicalTrials.gov record(s).

Program details

Company
Istituto Gentili S.r.l.
Indication
Cystic Fibrosis
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials